An overview of angiodysplasia: management and patient prospects. (2nd September 2018)

• Record Type: Journal Article
• Authors: Holleran, Grainne; McNamara, Deirdre
• Is Part Of: Expert review of gastroenterology & hepatology. Volume 12:Number 9(2018)
• Page Start: 863
• Page End: 872
• Publication Date: 2018-09-02
• Subjects: Angiodysplasia -- anemia -- angiogenesis -- bleeding -- small intestine; Gastroenterology -- Periodicals; Liver -- Diseases -- Periodicals; 616.3
• DOI: 10.1080/17474124.2018.1503532
• Languages: English
• ISSNs: 1747-4124

Abstract

ABSTRACT: Introduction : Gastrointestinal angiodysplasias (GIADs) have a wide variety of presentations, which can be significant and debilitating in a subset of patients. Endoscopic ablation is currently the most effective treatment for GIADs, however re-bleeding rates are high. Several medical have been used for GIADs and reported in the literature, however these medications have significant side effect profiles and randomized controlled trials are lacking. A relatively poor understanding of the pathophysiology of GIAD formation has limited the development of more effective treatments and improved diagnostic and prognostic markers for GIAD. However, recent advances in research in the area of angiogenesis have identified a potential role for certain angiogenic factors including Angiopoeitin 1 and 2, in the pathophysiology of GIAD. Areas covered : We performed an extensive pubmed search of all articles mentioning GIAD and summarized our findings focussing on patient management and prospects. We summarize the available literature regarding the medical, endoscopic, and radiological management of GIAD and the value of clinical prognostic factors. Expert commentary : Although the area of angiogenesis is a novel area of research in GIAD, it represents an exciting avenue for development with the potential to improve diagnostic and prognostic tools to improve patient outcome.